Journal
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Volume 85, Issue 2, Pages 207-213Publisher
AMER SOC TROP MED & HYGIENE
DOI: 10.4269/ajtmh.2011.10-0729
Keywords
-
Funding
- U.S. Public Health Service [T32GM007198, K24AI068903, R01AI45999, U19AI 089681, R01AI067727, D43TW007120]
- Medicines for Malaria Venture, Geneva, Switzerland
Ask authors/readers for more resources
Previous studies of Plasmodium vivax transmission to Anopheles spp. mosquitoes have not been able to predict mosquito infectivity on the basis of microscopic or molecular quantification of parasites (total parasites in the sample or total number of gametocytes) in infected blood. Two methods for production of P vivax ookinete cultures in vitro, with yields of 10(6) macrogametocytes, 10(4) zygotes, and 10(3) ookinetes, respectively, per 10 mL of P vivax-infected patient blood with approximately 0.01% parasitemia, were used to study P vivax sexual stage development. The quantity of gametocytes, determined by counting Giemsa-stained blood smears, and quantity and type of gametocyte as determined by quantitative reverse transcriptase polymerase chain reaction for Pvalpha tubulin II and macrogametocyte-specific pvg377 did not predict ookinete yield. Factors that affect the efficiency of in vitro P vivax ookinete transformation remain poorly understood.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available